Survey Finds Most Americans Unlikely to Enroll in Clinical Trials


Get Permission

According to a new survey of more than 1,500 consumers and nearly 600 physicians conducted for Memorial Sloan Kettering Cancer Center (MSK), only 35% of Americans indicated that they were “likely” to enroll in a clinical trial. Clinical research is increasingly dependent upon larger numbers of cancer patients participating. Fortunately, education makes a measurable and immediate difference. After reading a brief statement defining clinical trials, the number of respondents who had a positive impression of these studies jumped significantly, from 40% to 60%.

José Baselga, MD, PhD

José Baselga, MD, PhD

“If this trend of low enrollment continues, we will face a crisis in cancer research and discovery. Further education is the key to participation and progress,” said José Baselga, MD, PhD, Physician-in-Chief and Chief Medical Officer at MSK. ■


Advertisement

Advertisement



;
Advertisement

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.